Kerry J Rhoden
Overview
Explore the profile of Kerry J Rhoden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conti A, Strazzeri C, Rhoden K
Mol Cell Endocrinol
. 2020 Jul;
515:110922.
PMID: 32621861
Poly- and perfluoroalkyl substances (PFAS) are a class of endocrine disrupting chemicals (EDCs) reported to alter thyroid function. Iodide uptake by thyroid follicular cells, an early step in the synthesis...
2.
Diquigiovanni C, Bergamini C, Evangelisti C, Isidori F, Vettori A, Tiso N, et al.
Int J Cancer
. 2018 Apr;
143(7):1706-1719.
PMID: 29672841
Familial aggregation is a significant risk factor for the development of thyroid cancer and familial non-medullary thyroid cancer (FNMTC) accounts for 5-7% of all NMTC. Whole exome sequencing analysis in...
3.
Acquaviva G, Visani M, de Biase D, Marucci G, Franceschi E, Tosoni A, et al.
Sci Rep
. 2018 Mar;
8(1):4459.
PMID: 29535392
IDH mutational status is required for proper diagnosis according to the WHO criteria revised in 2016. The single nucleotide polymorphism (SNP) rs11554137 (IDH1) at codon 105 of IDH1 has been...
4.
Acquaviva G, Visani M, Repaci A, Rhoden K, de Biase D, Pession A, et al.
Histopathology
. 2017 Dec;
72(1):6-31.
PMID: 29239040
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular pathology of thyroid tumours originating from follicular cells has greatly advanced in the past several years. Common molecular...
5.
Volta U, Caio G, Boschetti E, Giancola F, Rhoden K, Ruggeri E, et al.
Dig Liver Dis
. 2016 Jun;
48(9):1018-22.
PMID: 27352981
Background: Although serological tests are useful for identifying celiac disease, it is well established that a minority of celiacs are seronegative. Aim: To define the prevalence and features of seronegative...
6.
Volta U, Caio G, Giancola F, Rhoden K, Ruggeri E, Boschetti E, et al.
Clin Gastroenterol Hepatol
. 2015 Nov;
14(5):686-93.e1.
PMID: 26538207
Background & Aims: Individuals with potential celiac disease have serologic and genetic markers of the disease with little or no damage to the small intestinal mucosa. We performed a prospective...
7.
Tallini G, de Biase D, Durante C, Acquaviva G, Bisceglia M, Bruno R, et al.
Mod Pathol
. 2015 Aug;
28(10):1343-59.
PMID: 26271724
Studies from single institutions have analyzed BRAF in papillary microcarcinomas, sometimes with contradictory results. Most of them have provided limited integration of histological and clinical data. To obtain a comprehensive...
8.
Iosco C, Cosentino C, Sirna L, Romano R, Cursano S, Mongia A, et al.
Cell Physiol Biochem
. 2014 Sep;
34(3):966-80.
PMID: 25201006
Background/aims: Iodide efflux from thyroid cells into the follicular lumen is essential for the synthesis of thyroid hormones, however, the pathways mediating this transport have only been partially identified. A...
9.
Marconi C, Brunamonti Binello P, Badiali G, Caci E, Cusano R, Garibaldi J, et al.
Eur J Hum Genet
. 2012 Oct;
21(6):613-9.
PMID: 23047743
Gnathodiaphyseal dysplasia (GDD) is an autosomal dominant syndrome characterized by frequent bone fractures at a young age, bowing of tubular bones and cemento-osseus lesions of the jawbones. Anoctamin 5 (ANO5)...
10.
Durante C, Tallini G, Puxeddu E, Sponziello M, Moretti S, Ligorio C, et al.
Eur J Endocrinol
. 2011 Jun;
165(3):455-63.
PMID: 21653734
Objective: Tyrosine kinase inhibitors (TKIs) are evaluated for treatment of radioiodine refractory thyroid cancer. Their effects in this setting are based on blockade of proangiogenic signaling mediated by receptors for...